Current Indications for the Implantable Cardioverter Defibrillator

Introduction. 4. Evolution of guidelines for defibrillator therapy. 5. Format of guidelines. 6. Background of ICD therapy. 7. Aims of ICD therapy. 7. Clinical efficacy of ICD therapy. 8. Alternatives to ICD therapy. 8. Comparison of drugs and devices. 10. Current indications for ICD therapy. 11. Contraindications to ICD therapy. 11. ICD therapy in specific disease states. 12. CAD. 12. Risk stratification. 13. Secondary prevention of cardiac arrest or sustained ventriculartachycardias in patients with coronary artery disease. 17. Primary prevention of sudden cardiac death after myocardialinfarction. 23. DCM... 26. Secondary prevention of cardiac arrest or sustained ventriculartachycardias in nonischemic dilated cardiomyopathy. 26. Primary prevention of sudden cardiac death. 27. Brugada syndrome. 33. Secondary prevention of cardiac arrest in patients with Brugadasyndrome. 34. Primary prevention of sudden death in patients with the BrugadaECG pattern. 35. Hypertrophic cardiomyopathy. 37. Secondary prevention of cardiac arrest or sustained ventriculartachycardias. 38. Primary prevention of sudden death in HCM... 39. Long QT syndrome. 43. Results of ICD therapy in patients with the long QT syndrome.46. Short QT Syndrome. 47. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) 48. Catecholamine- or exercise induced polymorphic ventriculartachycardia. 51. Other patients believed at high risk. 52. Defibrillators as a bridge to heart transplantation. 52. Cardiac Resynchronization Therapy (CRT) 53. Legal implications of defibrillator guidelines. 56. Literature. 64